These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26955658)

  • 21. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
    de Lastours V; Chau F; Roy C; Larroque B; Fantin B
    J Antimicrob Chemother; 2014 Dec; 69(12):3393-400. PubMed ID: 25063781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA Safety Reviews on Drugs, Biologics, and Vaccines: 2007-2013.
    Cope JU; Rosenthal GL; Weinel P; Odegaard A; Murphy DM
    Pediatrics; 2015 Dec; 136(6):1125-31. PubMed ID: 26598453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressive and Other Adverse CNS Effects of Fluoroquinolones.
    Wierzbiński P; Hubska J; Henzler M; Kucharski B; Bieś R; Krzystanek M
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004.
    Wang S; Zinderman C; Wise R; Braun M
    Cell Tissue Bank; 2007; 8(3):211-9. PubMed ID: 17278013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis.
    Ali AK
    Ann Epidemiol; 2014 Apr; 24(4):279-85. PubMed ID: 24472364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retrospective survey of fluoroquinolone use in children].
    Pariente-Khayat A; Vauzelle-Kervroedan F; d'Athis P; Bréart G; Gendrel D; Aujard Y; Olive G; Pons G
    Arch Pediatr; 1998 May; 5(5):484-8. PubMed ID: 9759180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.
    Michalak K; Sobolewska-Włodarczyk A; Włodarczyk M; Sobolewska J; Woźniak P; Sobolewski B
    Oxid Med Cell Longev; 2017; 2017():8023935. PubMed ID: 29147464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years.
    Bennett CL; Champigneulle O; Bennett A; Witherspoon B; Bove C
    Cancer Treat Res; 2022; 184():1-39. PubMed ID: 36449185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
    Ladewski LA; Belknap SM; Nebeker JR; Sartor O; Lyons EA; Kuzel TC; Tallman MS; Raisch DW; Auerbach AR; Schumock GT; Kwaan HC; Bennett CL
    J Clin Oncol; 2003 Oct; 21(20):3859-66. PubMed ID: 14551305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility.
    Mathews B; Thalody AA; Miraj SS; Kunhikatta V; Rao M; Saravu K
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31357640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the black box: drug- and device-associated hypersensitivity events.
    Bennett CL; Adegboro OS; Calhoun EA; Raisch D
    Drug Healthc Patient Saf; 2010; 2():1-5. PubMed ID: 21701613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
    Moro PL; Yue X; Lewis P; Haber P; Broder K
    Vaccine; 2011 Nov; 29(50):9404-8. PubMed ID: 21920404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.
    Hsu DI; Okamoto MP; Murthy R; Wong-Beringer A
    J Antimicrob Chemother; 2005 Apr; 55(4):535-41. PubMed ID: 15728150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.